 |
|
|
| |
BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN IN THE TREATMENT OF CHRONIC HEPATITIS C VIRUS GENOTYPE-1 INFECTED ASIAN PATIENTS IN THE SPRINT-1, SPRINT-2, AND RESPOND-2 TRIALS
|
| |
| |
Reported by Jules Levin
Presented at the 22nd Conference of the Asian Pacific Association for the Study of the Liver, February 16-19, 2012, Taipei City, Taiwan
K.Q. HU,1 F. ALVAREZ BOGNAR,2 S. THOMPSON,2 L. PEDICONE,2 J. WAHL,2 S.G. LIM3
1UNIVERSITY OF CALIFORNIA, IRVINE MEDICAL CENTER, ORANGE, CA, USA; 2MERCK SHARP & DOHME, WHITEHOUSE STATION, NJ, USA; 3NATIONAL UNIVERSITY HOSPITAL, SINGAPORE
|
| |
|
|
|
|
|
